Novozymes delivers strong 2021 full-year results and expects continued, solid progress in 2022
Retrieved on:
Tuesday, February 1, 2022
Growth, CEO, FCF, Climate, Water, Health, FMC, COVID-19, Carbon, Drink, Ethanol, Acquisition, Geography, DKK, Freshness, Zymer Bytyqi, Solution, Renewable energy, Fine chemical, Fertilizer, Food, Novozymes, Synergia, Bioenergy, Agriculture
Novozymes is executing on its strategic framework by delivering 6% organic sales growth for 2021 and presenting a solid organic growth outlook of 3-7% for 2022.
Key Points:
- Novozymes is executing on its strategic framework by delivering 6% organic sales growth for 2021 and presenting a solid organic growth outlook of 3-7% for 2022.
- We deliver highly satisfactory results for 2021, and I am proud to say that we expect continued, solid performance in 2022.
- Novozymes is built for growth and we have a strong foundation to accelerate our future performance.
- Despite continued challenges brought on by the Covid-19 pandemic, Novozymes made solid progress in 2021 and stayed the course to meet all except one of its 2022 targets and long-term commitments.